Clinical trial

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

NCT02764541

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2016-05-24

PhasePHASE2

Study timeline

Study start (actual)2016-05-24Date precision: day

Registry last updated2026-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

LetrozoleDRUG · verified · RxNorm: letrozole

TamoxifenDRUG · verified · RxNorm: tamoxifen

PalbociclibDRUG · verified · RxNorm: palbociclib

Endocrine TherapyDRUG

Sponsors & collaborators

Dana-Farber Cancer Institutelead sponsor

Pfizercollaborator

Mapped research locations

BostonMassachusetts, United States3 NashvilleTennessee, United States2 HoustonTexas, United States1 ProvidenceRhode Island, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02764541 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.